Acadia Healthcare Company, Inc. current report, 03 May 2018

Acadia Healthcare Company, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Form 8-K reports on the results of the Annual Meeting of Stockholders held by Acadia Healthcare Company, Inc. on May 3, 2018. The filing details the election of directors, the advisory vote on executive compensation, and the ratification of the independent auditor.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.

Material Changes and Voting Results

The following matters were submitted to a vote of security holders:

  • Election of Class I Directors:
    • E. Perot Bissell: Elected with 62,006,185 votes For, 19,656,014 Against, and 586,399 Abstain. Broker non-votes totaled 2,423,543.
    • Vicky B. Gregg: Elected with 81,417,291 votes For, 748,725 Against, and 82,582 Abstain. Broker non-votes totaled 2,423,543.
  • Executive Compensation (Say-on-Pay): Stockholders approved the compensation of Named Executive Officers on a non-binding advisory basis with 79,626,420 votes For, 2,389,671 Against, and 232,507 Abstain. Broker non-votes totaled 2,423,543.
  • Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2018, with 83,676,235 votes For, 954,319 Against, and 41,587 Abstain.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.

Key Facts for Investor Verification

  • Verify the significant number of votes cast against the election of director E. Perot Bissell (approximately 24% of votes cast excluding non-votes).
  • Confirm the term of the newly elected Class I directors, which extends until the 2021 annual meeting.
  • Note the ratification of Ernst & Young LLP as the auditor for the fiscal year ending December 31, 2018.
  • Review the definitive proxy statement filed on March 23, 2018, for details on the executive compensation package approved by shareholders.